Similar articles

• Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.

  Schroder JN, Daneshmand MA, Villamizar NR, Petersen RP, Blue LJ, Welsby IJ, Lodge AJ, Ortel TL, Rogers JG, Milano CA. Schroder JN, et al. Ann Thorac Surg. 2007 Sep;84(3):841-5; discussion 845-6. doi: 10.1016/j.athoracsur.2007.03.049. Ann Thorac Surg. 2007. PMID: 17720387
• Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.

  Creekmore FM, Oderda GM, Pendleton RC, Brixner DI. Creekmore FM, et al. Pharmacotherapy. 2006 Oct;26(10):1438-45. doi: 10.1592/phco.26.10.1438. Pharmacotherapy. 2006. PMID: 16999654
• Heparin-induced thrombocytopenia: a serious complication of heparin therapy for acute stroke.

  Kawano H, Toyoda K, Miyata S, Yamamoto H, Okamoto A, Kakutani I, Walenga JM, Naritomi H, Minematsu K. Kawano H, et al. Cerebrovasc Dis. 2008;26(6):641-9. doi: 10.1159/000166841. Epub 2008 Nov 4. Cerebrovasc Dis. 2008. PMID: 18984950
• Heparin-induced thrombocytopenia, a prothrombotic disease.

  Levy JH, Hursting MJ. Levy JH, et al. Hematol Oncol Clin North Am. 2007 Feb;21(1):65-88. doi: 10.1016/j.hoc.2006.11.003. Hematol Oncol Clin North Am. 2007. PMID: 17258119 Review.
• Heparin-induced thrombocytopenia.

  Demasi R, Bode AP, Knupp C, Bogey W, Powell S. Demasi R, et al. Am Surg. 1994 Jan;60(1):26-9. Am Surg. 1994. PMID: 8273970 Review.